OBJECTIVE: The current study was conducted to compare the diagnostic accuracy between (18)F-fluoro-2-deoxy-D: -glucose (FDG) positron emission tomography (PET)/computed tomography (CT), and conventional imaging (CI) for the staging and re-staging of patients with rhabdomyosarcomas. METHODS: Thirty-five patients who underwent FDG PET/CT prior to treatment were evaluated retrospectively. CI methods consisted of (99m)Tc-hydroxymethylene diphosphonate bone scintigraphy, chest radiograph, whole body CT, and magnetic resonance imaging of the primary site. The images were reviewed and two boardcertified radiologists reached a diagnostic consensus. Tumor stage was confirmed by histological examination and/or follow-up examinations. RESULTS: Interpretation on the basis of FDG PET/CT, and CI, diagnostic accuracies of the T and N stages were similar. Using FDG PET/CT, the M stage was correctly assigned in 31 patients (89%), whereas the accuracy of CI in M stage was 63%. TNM stage was correctly assessed with FDG PET/CT in 30 of 35 patients (86%) and with CI in 19 of 35 patients (54%). The overall TNM staging and M staging accuracies of FDG PET/CT were significantly higher than that of CI (P < 0.01). CONCLUSIONS: FDG PET/CT is more accurate than CI regarding clinical staging and re-staging of patients with rhabdomyosarcomas.
OBJECTIVE: The current study was conducted to compare the diagnostic accuracy between (18)F-fluoro-2-deoxy-D: -glucose (FDG) positron emission tomography (PET)/computed tomography (CT), and conventional imaging (CI) for the staging and re-staging of patients with rhabdomyosarcomas. METHODS: Thirty-five patients who underwent FDG PET/CT prior to treatment were evaluated retrospectively. CI methods consisted of (99m)Tc-hydroxymethylene diphosphonate bone scintigraphy, chest radiograph, whole body CT, and magnetic resonance imaging of the primary site. The images were reviewed and two boardcertified radiologists reached a diagnostic consensus. Tumor stage was confirmed by histological examination and/or follow-up examinations. RESULTS: Interpretation on the basis of FDG PET/CT, and CI, diagnostic accuracies of the T and N stages were similar. Using FDG PET/CT, the M stage was correctly assigned in 31 patients (89%), whereas the accuracy of CI in M stage was 63%. TNM stage was correctly assessed with FDG PET/CT in 30 of 35 patients (86%) and with CI in 19 of 35 patients (54%). The overall TNM staging and M staging accuracies of FDG PET/CT were significantly higher than that of CI (P < 0.01). CONCLUSIONS: FDG PET/CT is more accurate than CI regarding clinical staging and re-staging of patients with rhabdomyosarcomas.
Authors: Catalina Ruiz-Mesa; John M Goldberg; Alvaro J Coronado Munoz; Sarah N Dumont; Jonathan C Trent Journal: Curr Treat Options Oncol Date: 2015-06
Authors: Wojciech Kukwa; Piotr Wojtowicz; Beata Jagielska; Grzegorz Sobczyk; Andrzej Kukwa; Anna M Czarnecka Journal: BMC Cancer Date: 2011-05-12 Impact factor: 4.430
Authors: Monika Scheer; Tobias Dantonello; Peter Brossart; Dagmar Dilloo; Lothar Schweigerer; Simone Feuchtgruber; Monika Sparber-Sauer; Christian Vokuhl; Stefan S Bielack; Thomas Klingebiel; Ewa Koscielniak; Thekla von Kalle Journal: Pediatr Radiol Date: 2018-01-24
Authors: Hanna Maria Fuglø; Simon Møller Jørgensen; Annika Loft; Dorrit Hovgaard; Michael M Petersen Journal: Eur J Nucl Med Mol Imaging Date: 2012-06-15 Impact factor: 9.236
Authors: Sara M Federico; Sheri L Spunt; Matthew J Krasin; Catherine A Billup; Jianrong Wu; Barry Shulkin; Gerald Mandell; M Beth McCarville Journal: Pediatr Blood Cancer Date: 2012-12-19 Impact factor: 3.167
Authors: Priyanka Jha; Andreas M J Frölich; Beth McCarville; Oscar M Navarro; Paul Babyn; Robert Goldsby; Heike Daldrup-Link Journal: Pediatr Radiol Date: 2010-02-24
Authors: Aaron R Weiss; Elizabeth R Lyden; James R Anderson; Douglas S Hawkins; Sheri L Spunt; David O Walterhouse; Suzanne L Wolden; David M Parham; David A Rodeberg; Simon C Kao; Richard B Womer Journal: J Clin Oncol Date: 2013-08-12 Impact factor: 44.544